Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease

Abstract Background Current quantitative approaches to assess chronic liver disease (CLD) severity have limitations. Further, portal vein thrombosis (PVT) pre-liver transplant (LT) is a major contributor to morbidity in CLD; the means of detecting and/or predicting PVT are limited. We sought to expl...

Full description

Bibliographic Details
Main Authors: Clayton S. Lewis, Khurram Bari, Changchun Xie, Kenneth E. Sherman, Marc Vasse, Patrick Van Dreden, Vladimir Y. Bogdanov
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-023-02695-6
_version_ 1797864564262436864
author Clayton S. Lewis
Khurram Bari
Changchun Xie
Kenneth E. Sherman
Marc Vasse
Patrick Van Dreden
Vladimir Y. Bogdanov
author_facet Clayton S. Lewis
Khurram Bari
Changchun Xie
Kenneth E. Sherman
Marc Vasse
Patrick Van Dreden
Vladimir Y. Bogdanov
author_sort Clayton S. Lewis
collection DOAJ
description Abstract Background Current quantitative approaches to assess chronic liver disease (CLD) severity have limitations. Further, portal vein thrombosis (PVT) pre-liver transplant (LT) is a major contributor to morbidity in CLD; the means of detecting and/or predicting PVT are limited. We sought to explore whether plasma coagulation factor activity levels can serve as a substitute for prothrombin time/international normalized ratio (PT/INR) in the Model for End-stage Liver Disease (MELD), and/or help assess the risk of PVT. Methods Plasma activity levels of Factor V (FV), Factor VIII (FVIII), Protein C (PC), and Protein S (PS) and the concentrations of D-dimer, sP-selectin, and asTF were assessed in two cohorts of CLD patients (ambulatory, n = 42; LT, n = 43). Results FV and PC activity levels strongly correlated with MELD scores, which enabled the development of a novel scoring system based on multiple linear regressions of the correlations of FV and PC activity with MELD-Na that substitutes PT/INR. Six-month and 1-year follow-up revealed that our novel approach was non-inferior to MELD-Na at predicting mortality. A significant inverse correlation between FVIII activity levels and PVT was found in the LT cohort (p = 0.010); FV and PS activity levels were in-trend (p = 0.069, p = 0.064). We developed a logistic regression-based compensation score to identify patients at risk of PVT. Conclusions We demonstrate that FV and PC activity levels may be used to replace PT/INR in MELD scoring. We also show the potential of using the combination of FV, FVIII, and PS activity levels to assess the risk of PVT in CLD.
first_indexed 2024-04-09T22:53:55Z
format Article
id doaj.art-761ed85df5c44bdd82f2eec79fb27af3
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-04-09T22:53:55Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-761ed85df5c44bdd82f2eec79fb27af32023-03-22T11:23:01ZengBMCBMC Gastroenterology1471-230X2023-03-0123111210.1186/s12876-023-02695-6Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver diseaseClayton S. Lewis0Khurram Bari1Changchun Xie2Kenneth E. Sherman3Marc Vasse4Patrick Van Dreden5Vladimir Y. Bogdanov6Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of MedicineDivision of Digestive Diseases, Department of Internal Medicine, University of Cincinnati College of MedicineDepartment of Environmental and Public Health Sciences, University of Cincinnati College of MedicineDivision of Digestive Diseases, Department of Internal Medicine, University of Cincinnati College of MedicineDepartment of Biology and UMR INSERM 1176, Foch HospitalDiagnostica StagoDivision of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of MedicineAbstract Background Current quantitative approaches to assess chronic liver disease (CLD) severity have limitations. Further, portal vein thrombosis (PVT) pre-liver transplant (LT) is a major contributor to morbidity in CLD; the means of detecting and/or predicting PVT are limited. We sought to explore whether plasma coagulation factor activity levels can serve as a substitute for prothrombin time/international normalized ratio (PT/INR) in the Model for End-stage Liver Disease (MELD), and/or help assess the risk of PVT. Methods Plasma activity levels of Factor V (FV), Factor VIII (FVIII), Protein C (PC), and Protein S (PS) and the concentrations of D-dimer, sP-selectin, and asTF were assessed in two cohorts of CLD patients (ambulatory, n = 42; LT, n = 43). Results FV and PC activity levels strongly correlated with MELD scores, which enabled the development of a novel scoring system based on multiple linear regressions of the correlations of FV and PC activity with MELD-Na that substitutes PT/INR. Six-month and 1-year follow-up revealed that our novel approach was non-inferior to MELD-Na at predicting mortality. A significant inverse correlation between FVIII activity levels and PVT was found in the LT cohort (p = 0.010); FV and PS activity levels were in-trend (p = 0.069, p = 0.064). We developed a logistic regression-based compensation score to identify patients at risk of PVT. Conclusions We demonstrate that FV and PC activity levels may be used to replace PT/INR in MELD scoring. We also show the potential of using the combination of FV, FVIII, and PS activity levels to assess the risk of PVT in CLD.https://doi.org/10.1186/s12876-023-02695-6Liver diseasesVenous thrombosisFactor VFactor VIIIProtein C
spellingShingle Clayton S. Lewis
Khurram Bari
Changchun Xie
Kenneth E. Sherman
Marc Vasse
Patrick Van Dreden
Vladimir Y. Bogdanov
Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease
BMC Gastroenterology
Liver diseases
Venous thrombosis
Factor V
Factor VIII
Protein C
title Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease
title_full Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease
title_fullStr Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease
title_full_unstemmed Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease
title_short Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease
title_sort potential utility of a multi component coagulation factor panel to calculate meld scores and assess the risk of portal vein thrombosis in chronic liver disease
topic Liver diseases
Venous thrombosis
Factor V
Factor VIII
Protein C
url https://doi.org/10.1186/s12876-023-02695-6
work_keys_str_mv AT claytonslewis potentialutilityofamulticomponentcoagulationfactorpaneltocalculatemeldscoresandassesstheriskofportalveinthrombosisinchronicliverdisease
AT khurrambari potentialutilityofamulticomponentcoagulationfactorpaneltocalculatemeldscoresandassesstheriskofportalveinthrombosisinchronicliverdisease
AT changchunxie potentialutilityofamulticomponentcoagulationfactorpaneltocalculatemeldscoresandassesstheriskofportalveinthrombosisinchronicliverdisease
AT kennethesherman potentialutilityofamulticomponentcoagulationfactorpaneltocalculatemeldscoresandassesstheriskofportalveinthrombosisinchronicliverdisease
AT marcvasse potentialutilityofamulticomponentcoagulationfactorpaneltocalculatemeldscoresandassesstheriskofportalveinthrombosisinchronicliverdisease
AT patrickvandreden potentialutilityofamulticomponentcoagulationfactorpaneltocalculatemeldscoresandassesstheriskofportalveinthrombosisinchronicliverdisease
AT vladimirybogdanov potentialutilityofamulticomponentcoagulationfactorpaneltocalculatemeldscoresandassesstheriskofportalveinthrombosisinchronicliverdisease